[ad_1]
Although the findings are confirmed, the researchers believe that even a low level of efficacy would be more beneficial than currently available drugs for patients with Alzheimer's disease. The drug could not repair the damage already caused by the cognitive state, but slow down its progression.
[ad_2]
Source link
